[Sodium-glucose cotransporter type 2 inhibitors (SGLT2): from familial renal glucosuria to the treatment of type 2 diabetes mellitus].

Pérez López, G

[Sodium-glucose cotransporter type 2 inhibitors (SGLT2): from familial renal glucosuria to the treatment of type 2 diabetes mellitus]. [electronic resource] - Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 2010 - 618-25 p. digital

Publication Type: Journal Article; Review

0211-6995

10.3265/Nefrologia.pre2010.Sep.10494 doi


Absorption
Animals
Benzhydryl Compounds
Diabetes Mellitus, Experimental--drug therapy
Diabetes Mellitus, Type 2--drug therapy
Dogs
Double-Blind Method
Gluconeogenesis--drug effects
Glucose--metabolism
Glucosides--adverse effects
Glycosuria, Renal--drug therapy
Homeostasis
Humans
Hypoglycemic Agents--pharmacology
Kidney--metabolism
Kidney Tubules, Proximal--metabolism
Mice
Phlorhizin--adverse effects
Randomized Controlled Trials as Topic
Sodium-Glucose Transporter 1--physiology
Sodium-Glucose Transporter 2--genetics
Sodium-Glucose Transporter 2 Inhibitors